Equasens: sales down 4% in 1st half

(CercleFinance.com) - Equasens posted sales of €108 million for the first six months of 2024, down 4.
1% (-5.7% on a like-for-like basis), although the decline slowed between the first (-5.2%) and second quarters (-3%).

The contribution of external growth offsets the Ségur base effect", says the healthcare IT solutions group, adding that its hardware divisions "remain strongly impacted by the economic situation".

In terms of outlook, Equasens expects to return to growth in the second half of the year. Maintaining its investment policy and the unfavorable economic climate will have an impact on profitability in 2024", it warns.

Copyright (c) 2024 CercleFinance.com. All rights reserved.